Article Name Predictive Diagnostics
Akrivia Biosciences has introduced a novel framework that redefines how cancer genomes are interpreted
25th March, 2026
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care
25th March, 2026
A key milestone in this journey is DeepHealth’s acquisition of Gleamer, which expands its capabilities in X-ray interpretation and automated reporting
23rd March, 2026
This collaboration is a key strategic milestone in the continued expansion of Trinity Biotech’s New York State Department of Health
23rd March, 2026
Expands presence in Madhya Pradesh, bringing reliable, accurate and affordable diagnostic services across the region
20th March, 2026
Data Across 29 Presentations Highlights Precision, Accessibility and Platform-Agnostic Adoption, Establishing ALZpath’s Proprietary pTau217 as a Highly Accurate Industry Benchmark
18th March, 2026
QuidelOrtho is strengthening its global immunoassay offering through a new partnership aimed at expanding assay availability beyond its existing VITROS diagnostic system portfolio
12th March, 2026
As part of this strategic move, BPL Medical Technologies has launched BM Tech’s advanced bone mineral density measuring machines in India and Dubai
11th March, 2026
First-in-class solution consolidates multiple assays into a single test, enabling broader viral detection, faster time-to-result and more confident decision-making in regulated biopharmaceutical quality control
10th March, 2026
Singapore’s healthcare system has long been recognised for its strong infrastructure, advanced medical capabilities, and forward-looking policies. In recent years, however, the focus of healthcare development has expanded beyond treatment and hospital care to include a stronger emphasis on preventive healthcare.
09th March, 2026
This initiative supports the Government of India’s Make in India vision by strengthening the domestic endoscopy base while improving access to minimally invasive diagnostic technologies
27th February, 2026
The P-Cure centre is the first and only facility in the world to routinely deliver proton therapy to patients using its upright technology
17th February, 2026
Agreement adds new analyser platforms and expands assay menu across key international markets
16th February, 2026
Expected to Drive Gross Margin Expansion, Improve Working Capital Efficiency, and Enhance Long-Term Scalability
11th February, 2026
This agreement follows the memorandum of understanding (MoU) signed between the two companies in December 2024
09th February, 2026
BMC128 was developed by Biomica, Evogene’s subsidiary, and is currently completing a Phase 1 clinical study, showing promising early clinical results
06th February, 2026
Submission utilises the comprehensive five-analyte panel and algorithm that formed the basis for Quanterix’s LucentAD Complete LDT
04th February, 2026
The ZEISS ARTEVO 750 ophthalmic microscope is another breakthrough in ZEISS's ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE)
03rd February, 2026
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer